Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston MA, USA.
Department of Medicine, Beth Israel Deaconess Medical Center, Boston MA, USA.
Inflamm Bowel Dis. 2020 Aug 20;26(9):1319-1329. doi: 10.1093/ibd/izaa011.
Patients with inflammatory bowel disease (IBD) have an increased risk of colorectal cancer. We sought to assess the comparative efficacy of virtual chromoendoscopy (VCE) vs high definition white light endoscopy (HDWLE) or dye-spraying chromoendoscopy (DCE) through a meta-analysis and rating the quality of evidence.
A systematic review of the literature was performed through February 15, 2019. Primary outcomes were number of patients in whom dysplasia was identified and number of dysplastic lesions identified in these patients. We included only randomized control trials (RCTs) and performed meta-analysis using RevMan5.3.
Of the 3205 studies identified, 11 RCTs were included, with a total of 1328 patients. Per patient analysis, VCE was not statistically different compared with DCE (risk ratio [RR] 0.77; 95% CI, 0.55-1.08) or HDWLE (RR 0.72; 95% CI, 0.45-1.15). However, per dysplasia analysis, VCE was not statistically different compared with DCE (RR 0.72; 95% CI, 0.47-1.11) and inferior compared with HDWLE (RR 0.62; 95% CI, 0.44-0.88). The quality of evidence was moderate in the HDWLE and low to moderate in the DCE studies.
Based on this meta-analysis, VCE was as good as HDWLE and DCE in identifying dysplasia per patient analysis. However, per dysplasia analysis, VCE was inferior compared with HDWLE and no different from DCE. Further studies need to examine the efficacy of each individual VCE technique.
炎症性肠病(IBD)患者结直肠癌风险增加。我们通过荟萃分析和评估证据质量,旨在评估虚拟染色内镜(VCE)与高清白光内镜(HDWLE)或染料喷洒染色内镜(DCE)的比较疗效。
通过 2019 年 2 月 15 日的文献系统回顾。主要结果是确定异型增生的患者数量和这些患者中发现的异型增生病变数量。我们仅纳入随机对照试验(RCT),并使用 RevMan5.3 进行荟萃分析。
在 3205 项研究中,有 11 项 RCT 纳入研究,共有 1328 名患者。在每个患者的分析中,VCE 与 DCE(风险比 [RR] 0.77;95%置信区间,0.55-1.08)或 HDWLE(RR 0.72;95%置信区间,0.45-1.15)相比没有统计学差异。然而,在每个异型增生的分析中,VCE 与 DCE(RR 0.72;95%置信区间,0.47-1.11)相比没有统计学差异,并且与 HDWLE(RR 0.62;95%置信区间,0.44-0.88)相比处于劣势。HDWLE 的证据质量为中度,DCE 研究的证据质量为低至中度。
基于这项荟萃分析,VCE 在每个患者的分析中与 HDWLE 和 DCE 一样能够识别异型增生。然而,在每个异型增生的分析中,VCE 与 HDWLE 相比处于劣势,与 DCE 无差异。需要进一步研究来检验每种单独的 VCE 技术的疗效。